Field Of Vision
Copyright ©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Aug 7, 2012; 18(29): 3782-3786
Published online Aug 7, 2012. doi: 10.3748/wjg.v18.i29.3782
Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease
Luca Valenti, Paola Dongiovanni, Silvia Fargion
Luca Valenti, Paola Dongiovanni, Silvia Fargion, Università degli Studi di Milano, Fondazione Ca’ Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milano, Italy
Author contributions: All authors read, revised and approved the final manuscript version.
Supported by First Università degli Studi di Milano 2007, 2008, to Valenti L and Fargion S; Ricerca corrente Ospedale Maggiore Policlinico 2006 and 2008, to Valenti L and Fargion S; and Centro per lo Studio delle Malattie del Fegato e del Metabolismo.
Correspondence to: Dr. Luca Valenti, MD, Università degli Studi di Milano, Fondazione Ca’ Granda IRCCS, pad. Granelli, Ospedale Maggiore Policlinico, via F Sforza 35, 20122 Milano, Italy.
Telephone: +39-25-320278 Fax: +39-25-320296
Received: May 29, 2012
Revised: June 15, 2012
Accepted: June 28, 2012
Published online: August 7, 2012

Nonalcoholic fatty liver disease (NAFLD), defined by excessive liver fat deposition related to the metabolic syndrome, is a leading cause of progressive liver disease, for which accurate non-invasive staging systems and effective treatments are still lacking. Evidence has shown that increased ferritin levels are associated with the metabolic insulin resistance syndrome, and higher hepatic iron and fat content. Hyperferritinemia and iron stores have been associated with the severity of liver damage in NAFLD, and iron depletion reduced insulin resistance and liver enzymes. Recently, Kowdley et al demonstrated in a multicenter study in 628 adult patients with NAFLD from the NAFLD-clinical research network database with central re-evaluation of liver histology and iron staining that the increased serum ferritin level is an independent predictor of liver damage in patients with NAFLD, and is useful to identify NAFLD patients at risk of non-alcoholic steatohepatitis and advanced fibrosis. These data indicate that incorporation of serum ferritin level may improve the performance of noninvasive scoring of liver damage in patients with NAFLD, and that iron depletion still represents an attractive therapeutic target to prevent the progression of liver damage in these patients.

Keywords: Fibrosis, Ferritin, Iron overload, Nonalcoholic fatty liver disease, Steatohepatitis, Steatosis